Ömer DEMİR, Ahmet CİHAN, Aykut KEFİ, AHMET ADİL ESEN

Prematür ejakülasyon hastalarinin klinik ve demografik özelliklerinin değerlendirilmesi

Amaç: Çalışmamızda Prematür Ejakülasyon (PE) tanısı konulan hastaların klinik ve demografik özelliklerinin incelenmesi amaçlandı. Gereç ve yöntem: Kliniğimize erken boşalma nedeniyle Ocak-Haziran 2004 tarihleri arasında başvuran 53 hasta çalışmaya alındı. Hasta bilgilerine, cinsel işlev bozuklukları için oluşturulmuş Microsoft Access veri tabanından ulaşıldı. İlk cinsel ilişkiden itibaren PE yakınması olanlar Primer (PPE), yakınması daha sonra başlayan hastalar Akkiz PE (APE) olarak kabul edildi. Her iki grup yaş, eş yaşı, evlilik süresi, sünnet yaşı, nokturnal kontinans yaşı, PE süreleri, ilk koitus yaşı, ejakülasyon latans zamanı, ön sevişme süreleri, sistemik hastalıkları, uluslar arası prostat semptom skoru (IPSS), uluslar arası erektil fonksiyon indeksi (IIEF) ve Amerikan Ulusal Sağlık Örgütüprostatit (NIH-prostatit) skorları açısından karşılaştırıldı. Bulgular: Primer PE’li 27, APE’li 26 hastanın ortalama yaşları, sırasıyla 50,6 ± 12,3 (27–70 yıl) yıl ve 53,5 ± 10,4 (32–68 yıl) yıl olarak saptandı. Çalışmaya alınan hastaların 39’unda (%74) erektil disfonksiyon varlığı saptandı. Çalışmaya alınan hastaların ortalama sünnet yaşı 5,7 ± 2,6 (1–14) yıl, ilk koitus yaşı 19,0 ± 2,7 (13–29) yıl idi. Her iki grup arasında yaş, eş yaşı, evlilik süresi, sünnet yaşı, nokturnal kontinans yaşı, PE süreleri, ilk koitus yaşı, ejakülasyon latans zamanı, ön sevişme süreleri, IPSS, IIEF alt grupları ve NIH-prostatit skorları açısından anlamlı fark saptanmadı (p>0,05). Sistemik hastalık varlığı primer PE grubunda 9 hastada (%32) APE grubunda ise 19 hastada (%68) saptandı (p

Evalution of the clinical and demographic properties of patients with premature ejaculation

Objective: Aim of this study was to evaluate the demographic and clinic properties of men who were admitted to urology outpatient clinic with complaints of premature ejaculation (PE). Material and method: Total of 53 patients who admitted to urology outpatient clinics with the complaint of PE between January to June 2004 were enrolled the study. Patient data were taken from the Microsoft Access database that consisted for sexual function disorders. Patients were group as primary (PPE) and acquired PE (APE). Primary PE is characterized by onset from the first sexual experience, remains so during life and ejaculation occurs too fast (before vaginal penetration or < 1–2 min after). Acquired PE is characterized by a gradual or sudden onset following normal ejaculation experiences before onset and time to ejaculation is short. Both groups were compared for patients’ and partner’s age, marriage duration, circumcision age, ejaculation latency time (ELT), foreplay duration, systemic diseases, International Prostate Symptom Score (IPSS), International Index of Erectile Function (IIEF) and National Institute of Health–Prostatitis (NIH-prostatitis) scores. Results: Mean age of the patients were 50.6 ± 12.3 (range 27-70 years) years and 53.5 ± 10.4 (range 32-68) years in PPE (n=27) and APE patients (n=26), respectively (p>0.05). Of the 53 patients 14 (74%) had erectile dysfunction. Mean circumcision age of the total 65 patients was 5.9 ± 2.8 (range 1–14) years. First coitus age was 19.4 ± 3.1 (range 13–29) years. There were no significant differences between two groups in the mean of age, partners’ age, marriage duration, circumcision age, nocturnal continence age, first coitus age, ELT, foreplay duration, IPSS, IIEF doamins and NIHprostatitis scores. The presence of systemic disease was detected in 9 patients (32%) in PPE group and 19 patients (68%) in APE group (p<0.05). The most common detected diseases were diabetes and cardiovascular diseases. Conclusion: Our results showed that the majority of the patients with PE had ED. The co occurrence of PE and ED should be questioned in patients admitted to an andrology outpatient clinic who had the history of cardiovascular diseases and diabetes mellitus.

PDF

___

1. Colpi G, Weidner W, Jungwirth A et al. EAU guidelines on ejaculatory dysfunction. Eur Urol 2004; 46:555-558.
2. Montague DK, Jarow J, Broderick GA et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004; 172:290-294. Prematür ejakülasyon hastalarının klinik ve demografik özelliklerinin değerlendirilmesi 129
3. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002; 168: 2359-2367.
4. Waldinger MD. Lifelong premature ejaculation: from authority-based to evidence-based medicine. BJU Int 2005; 95:191.
5. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005; 2:492–497.
6. Waldinger MD. Premature ejaculation: state of the art. 2007; 34:591-599.
7. Jannini EA, Simonelli C, Lenzi A. Sexological approach to ejaculatory dysfunction. Int J Androl 2002; 25:317- 323.
8. Akkuş E, Kadıoğlu A, Esen A et al. Prevalence and correlates of erectile dysfunction in Turkey: a populationbased study. Eur Urol 2002;41:298-304.
9. Corona G, Petrone L, Mannucci E et al. Psychobiological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol 2004; 46:615-622.
10. Laumann EO, Nicolosi A, Glasser DB et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17:39–57.
11. Jannini EA, Lenzi A. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J Urol 2005; 23:68-75.
12. El-Sakka AI. Premature ejaculation in non-insulindependent diabetic patients. Int J Androl 2003; 26:329- 334.